Concepedia

Aliya Holland

AH

Statistics

Publications

6

Citations

572

H-Index

6

Active since

2021

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Swim Across America

Parker Institute for Cancer Immunotherapy

Aliya Holland is an author at Memorial Sloan Kettering Cancer Center specializing in tumor immunology, cancer immunotherapy, and checkpoint inhibitor therapy.

Publications per year

2021–2023

6

Publications

6

T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants

Daniel Hirschhorn, Sadna Budhu, Lukas Kraehenbuehl et al. · Cell · 2023 · 296 citations · Full text

, , +14

The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer

Andrew Chow, Fathema Uddin, Michael Liu et al. · Immunity · 2022 · 126 citations · Full text

, , +17

Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer

Neil H. Segal, Andrea Cercek, Geoffrey Y. Ku et al. · Clinical Cancer Research · 2021 · 86 citations · Full text

, , +17

Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade

Arnab Ghosh, Judith Michels, Riccardo Mezzadra et al. · Journal of Clinical Investigation · 2022 · 26 citations · Full text

, , +17

Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma

Lukas Kraehenbuehl, Aliya Holland, Emma Armstrong et al. · Cancers · 2022 · 22 citations · Full text

, , +17

1–5 of 6